Viewing Study NCT00855361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:11 PM
Ignite Modification Date: 2026-02-03 @ 2:19 PM
Study NCT ID: NCT00855361
Status: COMPLETED
Last Update Posted: 2013-04-29
First Post: 2009-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastroesophageal Reflux View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastroesophageal Reflux View
None Erosive Gastroesophageal Reflux Disease View
None Ulcerative Gastroesophageal Reflux Disease View
None Endoscopy View
None Pediatrics View
None GERD View
None Rabeprazole, Rabeprazole sodium View
None AcipHex View